Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European L…
Eckardt JN; Bill M; Rausch C; Metzeler K; Spiekermann K; Stasik S; Sauer T; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Krug U; Wörmann B; Hiddemann W; Görlich D; Sauerland C; Steffen B; Einsele H; Neubauer A; Burchert A; Schäfer-Eckart K; Berdel WE; Schliemann C; Krause SW; Hänel M; Hanoun M; Kaufmann M; Fransecky L; Braess J; Ruhnke L; Schetelig J; Middeke JM; Serve H; Baldus CD; Platzbecker U; Müller-Tidow C; Bornhäuser M; Herold T; Thiede C; Röllig C.
Leukemia
(Unknown)
Published: 2023
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic t…
Mori M; Kubota Y; Durmaz A; Gurnari C; Goodings C; Adema V; Ponvilawan B; Bahaj WS; Kewan T; LaFramboise T; Meggendorfer M; Haferlach C; Barnard J; Wlodarski M; Visconte V; Haferlach T; Maciejewski JP.
Leukemia
(Unknown)
Published: 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia.
Eifert T; Hsu CJ; Becker AL; Graessle S; Horne A; Bemmann F; Zhang Q; Heuser M; Vasioukhin V; Scholl S; Hochhaus A; Siegerist F; Endlich N; Bullinger L; Lane SW; Haas S; Schnoeder TM; Heidel FH.
Leukemia
(Unknown)
Published: 2023
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML.
Othman J; Potter N; Mokretar K; Taussig D; Khan A; Krishnamurthy P; Latif AL; Cahalin P; Aries J; Amer M; Belsham E; Conneally E; Craddock C; Culligan D; Dennis M; Duncan C; Freeman SD; Furness C; Gilkes A; Gkreka P; Hodgson K; Ingram W; Jain M; King A; Knapper S; Kottaridis P; McMullin MF; Mohite U; Ngu L; O'Nions J; Patrick K; Rider T; Roberts W; Severinsen MT; Storrar N; Taylor T; Russell NH; Dillon R.
Leukemia
(Unknown)
Published: 2023
A C/ebpα isoform specific differentiation program in immortalized myelocytes.
Leukemia
(Unknown)
Published: 2023
EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma.
Chemlal D; Varlet E; Machura A; Ovejero S; Requirand G; Robert N; Cartron G; Alaterre E; Bret C; Vincent L; Herbaux C; Cavalli G; Bruyer A; De Boussac H; Moreaux J.
Leukemia
(Unknown)
Published: 2023
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA)…
Cuglievan B; Connors J; He J; Khazal S; Yedururi S; Dai J; Garces S; Quesada AE; Roth M; Garcia M; McCall D; Gibson A; Ragoonanan D; Petropoulos D; Tewari P; Nunez C; Mahadeo KM; Tasian SK; Lamble AJ; Pawlowska A; Hammond D; Maiti A; Haddad FG; Senapati J; Daver N; Gangat N; Konopleva M; Meshinchi S; Pemmaraju N.
Leukemia
(Unknown)
Published: 2023
Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia.
Morales ML; García-Vicente R; Rodríguez-García A; Reyes-Palomares A; Vincelle-Nieto Á; Álvarez N; Ortiz-Ruiz A; Garrido-García V; Giménez A; Carreño-Tarragona G; Sánchez R; Ayala R; Martínez-López J; Linares M.
Leukemia
(Unknown)
Published: 2023
Activation of distinct inflammatory pathways in subgroups of LR-MDS.
Schneider M; Rolfs C; Trumpp M; Winter S; Fischer L; Richter M; Menger V; Nenoff K; Grieb N; Metzeler KH; Kubasch AS; Sockel K; Thiede C; Wu J; Woo J; Brüderle A; Hofbauer LC; Lützner J; Roth A; Cross M; Platzbecker U.
Leukemia
(Unknown)
Published: 2023
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed mul…
Ocio EM; Perrot A; Bories P; San-Miguel JF; Blau IW; Karlin L; Martinez-Lopez J; Wang SY; Bringhen S; Marcatti M; Mateos MV; Rodriguez-Otero P; Oliva S; Nogai A; Le Roux N; Dong L; Macé S; Gassiot M; Fitzmaurice T; Oprea C; Moreau P.
Leukemia
(Unknown)
Published: 2023
Targeting miR-126 in Ph+ acute lymphoblastic leukemia.
Qiao J; Zhao D; Nguyen LXT; Chen F; Liang C; Estrella K; Ghoda LY; Heisterkamp N; Marcucci EC; Kuo YH; Marcucci G; Zhang B.
Leukemia
(Unknown)
Published: 2023
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect.
Guardalupi F; Sorrentino C; Corradi G; Giancola R; Baldoni S; Ulbar F; Fabi B; Andres Ejarque R; Timms J; Restuccia F; Santarone S; Accorsi P; Sportoletti P; De Falco F; Rosati E; Carotti A; Falzetti F; Velardi A; Martelli MF; Kordasti S; Pierini A; Ruggeri L; Di Ianni M.
Leukemia
(Unknown)
Published: 2023
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with …
Nikitin E; Kislova M; Morozov D; Belyakova V; Suvorova A; Sveshnikova J; Vyscub G; Matveeva I; Shirokova M; Shipaeva A; Klitochenko T; Makarovskaya P; Dmitrieva E; Biderman B; Sudarikov A; Obukhova T; Samoilova O; Kaplanov K; Konstantinova T; Mayorova O; Poddubnaya I; Ptushkin V.
Leukemia
(Unknown)
Published: 2023
UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.
Rizq O; Mimura N; Oshima M; Momose S; Takayama N; Itokawa N; Koide S; Shibamiya A; Miyamoto-Nagai Y; Rizk M; Nakajima-Takagi Y; Aoyama K; Wang C; Saraya A; Ito R; Seimiya M; Watanabe M; Yamasaki S; Shibata T; Yamaguchi K; Furukawa Y; Chiba T; Sakaida E; Nakaseko C; Tamaru JI; Tai YT; Anderson KC; Honda H; Iwama A.
Leukemia
(Unknown)
Published: 2023
Relationship among three common hematological premalignant conditions.
Boddicker NJ; Parikh SA; Norman AD; Rabe KG; Griffin R; Call TG; Robinson DP; Olson JE; Dispenzieri A; Rajkumar V; Kumar S; Kay NE; Hanson CA; Cerhan JR; Murray D; Braggio E; Shanafelt TD; Vachon CM; Slager SL.
Leukemia
(Unknown)
Published: 2023